Edition:
United Kingdom

Checkpoint Therapeutics Inc (CKPT.OQ)

CKPT.OQ on NASDAQ Stock Exchange Capital Market

2.30USD
7 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.30
Open
$2.20
Day's High
$2.32
Day's Low
$2.20
Volume
4,201
Avg. Vol
30,351
52-wk High
$6.30
52-wk Low
$1.98

Chart for

About

Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology... (more)

Overall

Beta: --
Market Cap(Mil.): $176.31
Shares Outstanding(Mil.): 25.37
Dividend: --
Yield (%): --

Financials

Special Report: Biotech incubator taps investors through in-house brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman

02 Aug 2018

Biotech incubator taps investors through in-house brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman

02 Aug 2018

SPECIAL REPORT-Biotech incubator taps investors through in-house brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman

02 Aug 2018

Earnings vs. Estimates